Internal Medicine Doctors in Vestavia, AL Accepting Medicare
7 Internal Medicine doctors found. Showing 1 - 7
 Dr. Tofey James Leon Iv, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3140 Cahaba Heights Rd, Vestavia, AL 35243 Phone: 205-967-7302 |
 Caroline Howard Studdard, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8000 Liberty Pkwy Ste 114, Vestavia, AL 35242 Phone: 205-968-5988 Fax: 205-968-5990 |
Dr. Laquetta Nicol Pettway, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1360 Montgomery Hwy, Suite 114, Vestavia, AL 35216 Phone: 205-978-7550 Fax: 205-978-7551 |
Jian Feng, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2116 Montreat Ln Apt B, Vestavia, AL 35216 Phone: 205-567-5314 |
Archana Balasubramanya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1817 Surrey Oaks Ln, Vestavia, AL 35243 Phone: 423-767-4327 Fax: 423-928-1353 |
Dr. Hayes Williams, M.D., PHD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2017 Canyon Rd, Suite 41, Vestavia, AL 35216 Phone: 205-757-8212 Fax: 205-834-8111 |
Paula D Moore, M. D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2470 Rocky Ridge Rd, Suite 200, Vestavia, AL 35243 Phone: 205-286-3200 Fax: 205-286-3201 |
News Archive
Nanostructures improve bone response to titanium implants
Titanium implants were successfully introduced by P.-I. Branemark and co-workers in 1969 for the rehabilitation of edentulous jaws.
Gut-on-chips can predict effectiveness of candidate drugs
Research conducted at Leiden has established that guts-on-chips respond in the same way to aspirin as real human organs do. This is a sign that these model organs are good predictors of the effect of medical drugs on the human body. Publication in Nature Communications on 15 August.
Current information on the use of antidepressants in pediatric patients
The Food and Drug Administration has issued an update to provide health care providers and patients with the most current information on the use of antidepressants in pediatric patients.
Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
› Verified 8 days ago
Anesthesiology
Internal Medicine
Family Medicine
Psychiatry & Neurology
Ophthalmology
Orthopaedic Surgery
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Plastic Surgery
Pediatrics